The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 4,701–4,800 of 31,469
Nguyen, N. Q., Debreceni, T. L., Bambrick, J. E., Chia, B., Deane, A. M., Wittert, G., Rayner, C. K., Horowitz, M., & Young, R. L. (2014) · Obesity · doi:10.1002/oby.20829 · Cited by 76
Pedersen, L., Nybo, M., Poulsen, M. K., Henriksen, J. E., Dahl, J. S., & Rasmussen, L. M. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-196 · Cited by 73
van Dijk, T. H., Laskewitz, A. J., Grefhorst, A., Boer, T. S., Bloks, V. W., Kuipers, F., Groen, A. K., & Reijngoud, D. (2013) · Laboratory Animals · doi:10.1177/0023677212473714 · Cited by 74
Metabolic Syndrome and Insulin Resistance Significantly Correlate with Body Mass Index
Esteghamati, A., Khalilzadeh, O., Anvari, M., Ahadi, M. S., Abbasi, M., & Rashidi, A. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.08.004 · Cited by 77
Wallander, M., Bartnik, M., Efendić, S., Hamsten, A., Malmberg, K., Öhrvik, J., Rydén, L., Silveira, A. M. V., & Norhammar, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1931-z · Cited by 74
Influence of Visceral Obesity and Liver Fat on Vascular Structure and Function in Obese Subjects
Sturm, W., Sandhofer, A., Engl, J., Laimer, M. W., Molnar, C., Kaser, S., Weiss, H. G., Tilg, H., Ebenbichler, C. F., & Patsch, J. R. (2009) · Obesity · doi:10.1038/oby.2009.81 · Cited by 73
Bargut, T. C. L., Frantz, E. D. C., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2014) · Lipids · doi:10.1007/s11745-014-3892-9 · Cited by 76
Głowińska‐Olszewska, B., & Urban, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.011 · Cited by 73
Adipose Tissue Interleukin‐18 mRNA and Plasma Interleukin‐18: Effect of Obesity and Exercise
Leick, L., Lindegaard, B., Stensvold, D., Plomgaard, P., Saltin, B., & Pilegaard, H. (2007) · Obesity · doi:10.1038/oby.2007.528 · Cited by 73
Torres-Rovira, L., Astiz, S., Caro‐Vadillo, A., López-Bote, C. J., Óvilo, C., Pallarés, P., Perez-Solana, M., Sánchez, R. S., & Gonzalez‐Bulnes, A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/510149 · Cited by 74
Taniguchi, A., Nakai, Y., Sakai, M., Yoshii, S., Hamanaka, D., Hatae, Y., Kawata, M., Yamanouchi, K., Okumura, T., Doi, K., et al. (2002) · Metabolism · doi:10.1053/meta.2002.31984 · Cited by 73
Effects of two different somatostatin analogs on glucose tolerance in acromegaly
Ronchi, C. L., Epaminonda, P., Cappiello, V., Beck‐Peccoz, P., & Arosio, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345491 · Cited by 73
Valéra, B., Dewailly, É., & Poirier, P. (2008) · Environmental Health · doi:10.1186/1476-069x-7-29 · Cited by 73
Mediterranean diet improves sexual function in women with the metabolic syndrome
Esposito, K., Ciotola, M., Giugliano, F. M., Schisano, B., Riccardo Autorino, B., Iuliano, S., Vietri, M. T., Cioffi, M., SIO, M. D., & Giugliano, D. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901555 · Cited by 74
Been, L. F., Ralhan, S. K., Wander, G. S., Mehra, N. K., Singh, J., Mulvihill, J. J., Aston, C. E., & Sanghera, D. K. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-18 · Cited by 72
Massip, L., Garand, C., Turaga, R. V. N., Deschênes, F., Thorin, É., & Lebel, M. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.10.011 · Cited by 73
Dall, C. H., Gustafsson, F., Christensen, S. B., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.02.001 · Cited by 73
Verrijken, A., Francque, S., Mertens, I., Talloen, M., Peiffer, F., & van Gaal, L. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.4 · Cited by 74
Ndisang, J. F., Lane, N., & Jadhav, A. (2008) · Endocrinology · doi:10.1210/en.2008-0239 · Cited by 73
Macheret, F., Bartz, T. M., Djoussé, L., Ix, J. H., Mukamal, K. J., Zieman, S. J., Siscovick, D. S., Tracy, R. P., Heckbert, S. R., Psaty, B. M., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307015 · Cited by 73
Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C†
Jonsson, J. R., Barrie, H. D., O'Rourke, P. K., Clouston, A. D., & Powell, E. E. (2008) · Hepatology · doi:10.1002/hep.22311 · Cited by 73
van Genugten, R. E., van Raalte, D. H., & Diamant, M. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01473.x · Cited by 76
León‐Cabrera, S., Arana-Lechuga, Y., Esqueda-León, E., Terán-Pérez, G., González-Chávez, A., Escobedo, G., & Moctezuma, J. V. (2015) · Mediators of Inflammation · doi:10.1155/2015/493409 · Cited by 76
Kaya, C., Pabuçcu, R., Berker, B., & Şatıroğlu, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.070 · Cited by 74
Ballantyne, G. H., Farkas, D. T., Laker, S., & Wasielewski, A. (2006) · Obesity Surgery · doi:10.1381/096089206778392158 · Cited by 73
Maki, K. C., Fulgoni, V. L. I., Keast, D. R., Rains, T. M., Park, K. M., & Rubin, M. R. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0020 · Cited by 72
Iellamo, F., Caminiti, G., Sposato, B., Vitale, C., Massaro, M., Rosano, G. M. C., & Volterrani, M. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0980-4 · Cited by 75
Catalán, V., Gómez‐Ambrosi, J., Pastor, C., Rotellar, F., Silva, C., Rodrı́guez, A., Gil, M. J., Cienfuegos, J. A., Salvador, J., Vendrell, J. J., et al. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9453-7 · Cited by 71
Vaspin and its correlation with insulin sensitivity indices in obese children
Süleymanoğlu, S., Taşçılar, E., Pirgon, Ö., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.008 · Cited by 73
Risk Factors for Peripheral Arterial Disease Among Patients With Chronic Kidney Disease
Chen, J., Mohler, E. R., Xie, D., Shlipak, M. G., Townsend, R. R., Appel, L. J., Raj, D. S., OJO, A. O., Schreiber, M. J., Strauss, L., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.061 · Cited by 74
Esposito, K., Maiorino, M. I., Palo, C. D., Gicchino, M., Petrizzo, M., Bellastella, G., Saccomanno, F., & Giugliano, D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01367.x · Cited by 76
Poníachik, J., Csendes, A., Díaz, J. C., Flores, J. R., Patricio Burdiles, P., Maluenda, F., Smok, G., Rodrigo, R., & Videla, L. A. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.006 · Cited by 73
Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome
Maliqueo, M. A., Sir‐Petermann, T., Pérez, V., Echiburú, B., de Guevara, A. L., Gálvez, C., Crisosto, N., & Azziz, R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0427 · Cited by 73
Serum FGF-21 Levels in Type 2 Diabetic Patients
Cheng, X., Zhu, B. L., Jiang, F., & Fan, H. (2011) · Endocrine Research · doi:10.3109/07435800.2011.558550 · Cited by 73
Tsang, C., Smail, N. F., Almoosawi, S., Davidson, I., & Al‐Dujaili, E. A. S. (2012) · Journal of Nutritional Science · doi:10.1017/jns.2012.10 · Cited by 73
Vidigal, F. D. C., Ribeiro, A. Q., Babió, N., Salas‐Salvadó, J., & Bressan, J. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0003-x · Cited by 73
Wang, D., Zhu, W., Jie-ming, L., An, C., & Wang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081190 · Cited by 73
Ozgu-Erdinc, A. S., Yılmaz, S., Yeral, M. İ., Seçkin, K. D., Erkaya, S., & Danışman, A. N. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.973397 · Cited by 76
Koot, B. G. P., van der Baan‐Slootweg, O. H., Tamminga-Smeulders, C. L. J., Rijcken, T. H. P., Korevaar, J. C., van Aalderen, W. M. C., Jansen, P. L. M., & Benninga, M. A. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.199760 · Cited by 73
Koskinen, J. M., Magnussen, C. G., Sabin, M. A., Kähönen, M. A. P., Hutri‐Kähönen, N., Laitinen, T. P., Taittonen, L. M., Jokinen, E. V., Lehtimäki, T. J., Viikari, J. S. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0008 · Cited by 70
Soriguer, F., Esteva, I., Rojo‐Martínez, G., Adana, R. D., Dobarganes, M., Garcia-Almeida, J., Tinahones, F. J., Beltran, M., González‐Romero, S., Olveira, G., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500033 · Cited by 75
Oh, J. Y., Sung, Y., & Lee, H. J. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.2.180 · Cited by 73
Lin, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1753 · Cited by 73
Yavuz, D. G., Koç, M., Toprak, A. C., Akpınar, İ., Velioğlu, A., Deyneli, O., Haklar, G., & Akalln, S. (2003) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2003.032 · Cited by 73
Menopausal hot flashes and white matter hyperintensities
Thurston, R. C., Aizenstein, H. J., Derby, C. A., Sejdić, E., & Maki, P. M. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000481 · Cited by 73
Sanke, S., Chander, R., Jain, A., Garg, T., & Yadav, P. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.1776 · Cited by 73
Regular Exercise to Prevent the Recurrence of Gestational Diabetes Mellitus
Guelfi, K. J., Ong, M. J., Crisp, N. A., Fournier, P. A., Wallman, K. E., Grove, B., Doherty, D. A., & Newnham, J. P. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001632 · Cited by 75
Borghi, L., Leone, D., Vegni, E. A. M., Galiano, V., Lepadatu, C., Sulpizio, P., & Garzia, E. (2017) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2017.1311319 · Cited by 73
Zöhrer, E., Alisi, A., Jahnel, J., Mosca, A., Corte, C. D., Crudele, A., Fauler, G., & Nobili, V. (2017) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2016-0689 · Cited by 73
Giezenaar, C., Trahair, L., Luscombe-Marsh, N., Hausken, T., Standfield, S., Jones, K., Lange, K., Horowitz, M., Chapman, I., & Soenen, S. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.154377 · Cited by 70
Hu, Y., Liu, J., Yuan, Y., Chen, J., Cheng, S., Wang, H., & Xu, Y. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.09.002 · Cited by 73
Biolato, M., Manca, F., Marrone, G., Cefalo, C., Racco, S., Miggiano, G. A. D., Valenza, V., Gasbarrini, A., Miele, L., & Grieco, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i4.509 · Cited by 78
Mohamed‐Ali, Pinkney, J. H., Panahloo, Cwyfan‐Hughes, Hollý, & Yudkin (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00647.x · Cited by 73
Estrada, V., Serrano‐Ríos, M., Larrad, M. T. M., de Villar, N. G. P., López, A. G., Téllez, M. J., & Fernández, C. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200201010-00004 · Cited by 73
Sidhu, J. S., Cowan, D., & Kaski, J. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.051 · Cited by 73
Normal Glucose Tolerance and Gestational Diabetes Mellitus
Cianni, G. D., Seghieri, G., Lencioni, C., Cuccuru, I., Anichini, R., Bellis, A. D., Ghio, A., Tesi, F., Volpe, L., & Prato, S. D. (2007) · Diabetes Care · doi:10.2337/dc07-0119 · Cited by 74
Pérez-Torres, Y. Y., Jiménez‐Ferrer, E., Zamilpa, A., Hernández-Valencia, M., Alarcón-Aguilar, F. J., Tortoriello, J., & Román‐Ramos, R. (2007) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x07005491 · Cited by 73
Koba, S., Hirano, T., Kondo, T., Shibata, M., Suzuki, H., Murakami, M., Geshi, E., & Katagiri, T. (2002) · American Heart Journal · doi:10.1067/mhj.2002.126119 · Cited by 73
Sourij, H., Zweiker, R., & Wascher, T. C. (2006) · Diabetes Care · doi:10.2337/dc05-2226 · Cited by 73
Christiansen, T., Paulsen, S. K., Bruun, J. M., Overgaard, K., Ringgaard, S., Pedersen, S. B., Positano, V., & Richelsen, B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-1009 · Cited by 74
Muscle Irisin Response to Aerobic vs HIIT in Overweight Female Adolescents
Archundia-Herrera, C., Macias-Cervantes, M., Ruiz-Muñoz, B., Vargas-Ortiz, K., Kornhauser, C., & Perez-Vazquez, V. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0302-5 · Cited by 72
Association of (−)786T–C mutation of endothelial nitric oxide synthase gene with insulin resistance
K., O., Y., Y., S., G., R., H.-O., K., N., M., M., Y., K., & M., H. (2002) · Diabetologia · doi:10.1007/s00125-002-0922-6 · Cited by 71
SALEH, S., EL-MARAGHY, N., REDA, E., & BARAKAT, W. (2014) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201420140212 · Cited by 81
Hopkins, M., Gibbons, C., Caudwell, P., Hellström, P. M., Näslund, E. B., King, N. A., Finlayson, G., & Blundell, J. E. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.277 · Cited by 72
Thorning, T. K., Raziani, F., Bendsen, N. T., Astrup, A. V., Tholstrup, T., & Raben, A. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109116 · Cited by 72
Sung, K., Cha, S.-C., Sung, J.-W., So, M.-S., & Byrne, C. D. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.07.005 · Cited by 72
Metabolic biomarkers and gallstone disease – a population-based study
Shabanzadeh, D. M., Skaaby, T., Sørensen, L. T., Eugen‐Olsen, J., & Jørgensen, T. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1365166 · Cited by 74
A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease
Timmons, J. A., Atherton, P. J., Larsson, O. S., Sood, S., Blokhin, I. O., Brogan, R. J., Volmar, C., Josse, A. R., Slentz, C. A., Wahlestedt, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky570 · Cited by 70
Abundance of gut Prevotella at baseline and metabolic response to barley prebiotics
Sandberg, J. C., Kovatcheva‐Datchary, P., Björck, I., Bäckhed, F., & Nilsson, A. C. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1788-9 · Cited by 72
Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease
Runtsch, M. C., Nelson, M. C., Lee, S.-H., Voth, W. P., Alexander, M., Hu, R., Wallace, J. A., Petersen, C., Panic, V., Villanueva, C. J., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007970 · Cited by 74
Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test
Abbas, H. T., Alić, L., Erraguntla, M., Ji, J., Abdul‐Ghani, M. A., Abbasi, Q. H., & Qaraqe, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219636 · Cited by 78
Arakawa, R., Febres, G., Cheng, B., Krikhely, A., Bessler, M., & Körner, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236133 · Cited by 72
Cho, Y. K., Lee, J., Kim, H. S., Kim, H. S., Lee, M. J., Yang, D. H., Yang, D. H., Jung, C. H., Park, J., Kim, H.-K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010092 · Cited by 72
Factors Determining Insulin Resistance in Chronic Hemodialysis Patients
Hung, A. M., & Ikizler, T. A. (2011) · Contributions to nephrology · doi:10.1159/000327177 · Cited by 72
Androgenetic alopecia and insulin resistance in young men
González‐González, J. G., Mancillas‐Adame, L. G., Fernández‐Reyes, M., Gómez‐Flores, M., Lavalle-Gonzalez, F. J., Ocampo‐Candiani, J., & Villarreal‐Pérez, J. Z. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03508.x · Cited by 73
Ghafurniyan, H., Azarnia, M., Nabiuni, M., & Karimzadeh, L. (2015) · Europe PMC (PubMed Central) · Cited by 71
Effects of Ramadan fasting on glucose homeostasis and adiponectin levels in healthy adult males
Gnanou, J. V., Caszo, B. A., Khalil, K. M., Abdullah, S. L. B., Knight, V. F., & Bidin, M. Z. B. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0183-9 · Cited by 72
da Costa, A. M., Igualaacute, I., Bedini, J. L., Quintoacute, L., & Conget, I. (2002) · Metabolism · doi:10.1053/meta.2002.30523 · Cited by 72
Gu, P., Jiang, W., Lü, B., & Shi, Z. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.827697 · Cited by 73
Apolipoprotein M predicts pre‐β‐HDL formation: studies in type 2 diabetic and nondiabetic subjects
Plomgaard, P., Dullaart, R. P. F., Vries, R. D., Groen, A. K., Dahlbäck, B., & Nielsen, L. B. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02095.x · Cited by 72
Decorin is a secreted protein associated with obesity and type 2 diabetes
Bolton, K. A., Segal, D., McMillan, J. S., Jowett, J. B. M., Heilbronn, L. K., Abberton, K. M., Zimmet, P., Chisholm, D. J., Collier, G. R., & Walder, K. R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.41 · Cited by 71
High Body Mass Index is an Important Risk Factor for the Development of Type 2 Diabetes
Sanada, H., Yokokawa, H., Yoneda, M., Yatabe, J., Yatabe, M., Williams, S. M., Felder, R. A., & José, P. A. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7410 · Cited by 73
IL-6, IL-8 and IL-10 Levels in Healthy Weight and Overweight Children
Tam, C. S., Garnett, S. P., Cowell, C. T. C. T., Heilbronn, L. K., Lee, J. W., Wong, M., & Baur, L. A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000277632 · Cited by 72
Chen, C.-H., Huang, M., Kao, C., Lin, S., Kuo, P., Chiu, C.-C., & Lu, M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08186 · Cited by 72
Colizzi, M., Costa, R., Scaramuzzi, F., Palumbo, C., Tyropani, M., Pace, V., Quagliarella, L., Brescia, F., Natilla, L. C., Loverro, G., et al. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.001 · Cited by 73
Orio, F., Palomba, S., Cascella, T., Tauchmanovà, L., Nardo, L. G., Biase, S. D., Labella, D., Russo, T., Tolino, A., Zullo, F., et al. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61634-3 · Cited by 72
Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
Holman, R. R. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.006 · Cited by 72
Axelsson, J., Møller, H. J., Witasp, A., Qureshi, A. R., Carrero, J. J., Heimbürger, O., Barany, P. F., Alvestrand, A., Lindholm, B., Moestrup, S. K., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.022 · Cited by 72
Single Nucleotide Polymorphisms of TCF7L2 Are Linked to Diabetic Coronary Atherosclerosis
Muendlein, A., Saely, C. H., Geller-Rhomberg, S., Sonderegger, G., Rein, P., Winder, T. L., Beer, S., Vonbank, A., & Drexel, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017978 · Cited by 72
Zhu, Y., Wang, H., Hollis, J., & Jacques, P. F. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0735-7 · Cited by 73
El-Karaksy, H., El-Koofy, N. M., Anwar, G. M., El‐Raziky, M. S., El-Hennawy, A., El‐Mougy, F., Hassanin, F. S., & Helmy, H. M. (2012) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.91738 · Cited by 70
Insulin resistance: an independent risk factor for lung cancer?
Petridou, E. T., Sergentanis, T. Ν., Antonopoulos, C. N., Dessypris, N., Matsoukis, I. L., Aronis, K. N., Efremidis, A. P., Syrigos, C., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.002 · Cited by 72
Hirose, H., Takayama, T., Hozawa, S., Hibi, T., & Saito, I. (2011) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2011.09.005 · Cited by 72
Salomón, C., Westermeier, F., Puebla, C., Arroyo, P., Guzmán‐Gutiérrez, E., Pardo, F., Leiva, A., Casanello, P. C., & Sobrevía, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040578 · Cited by 72
Song, Y. S., Lee, S. K., Jang, Y. J., Park, H. S., Kim, J.-H., Lee, Y. J., & Heo, Y.-S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.002 · Cited by 72
Effect of phylloquinone supplementation on glucose homeostasis in humans
Kumar, R., Binkley, N., & Vella, A. V. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.30108 · Cited by 72
Lazarević, G., Antić, S., Cvetković, T., Vlahović, P., Tasic, I. S., & Stefanović, V. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70312-9 · Cited by 73
Crescenzo, R., Lionetti, L., Mollica, M. P., Ferraro, M., D’Andrea, E., Mainieri, D., Dulloo, A. G., Liverini, G., & Iossa, S. (2006) · Diabetes · doi:10.2337/db06-0312 · Cited by 72
Öhlin, B., Berglund, G. L., Rosvall, M., & Nilsson, P. M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32801220fa · Cited by 72
Utz, W., Engeli, S., Haufe, S., Kast, P., Hermsdorf, M., Wiesner, S., Pofahl, M., Traber, J., Luft, F. C., Boschmann, M., et al. (2011) · Heart · doi:10.1136/hrt.2011.224451 · Cited by 74
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
